Modified FOLFIRINOX (5-FU/LV, irinotecan and oxaliplatin) as second-line chemotherapy for gemcitabine-resistant or -refractory advanced pancreatic cancer
- All Author(s)
- S. C. Lee
; K. Lee
; S. B. Bae
; H. J. Kim
; S. Y. Oh
; S. Y. Song
; D. S. Hong
; J. Yoon
; D. H. Lim
; S. I. Lee
; J. H. Won
; N. Lee
; K. Kim
; H. W. Lee
; H. R. Lee
; E. M. Nam
; J. S. Jang
; I. G. Hwang
; J. H. Kang
- Intsitutional Author(s)
- 이상철; 이규택; 배상병; 김한조
- Issued Date
- 2015
- Type
- Conference
- Conference Name
- European Cancer Congress 2015
- Conference Date
- 42272
- dc_citation_conferenceCountry
- Austria
- Citation Publisher
- ECCO
ESMO
ESTRO
ESSO
EACR
EONS
SIOPE
- Citation Title
- European Journal of Cancer
- Citation Start Page
- S456
- Citation End Page
- S456
- Language(ISO)
- eng
- DOI
- 10.1016/S0959-8049(16)31277-1
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/4367
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.